Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial

BACKGROUND: Chronic oxaliplatin-induced peripheral neurotoxicity (OIPN) is the most troublesome and dose-limiting side effect of oxaliplatin. There is no effective treatment for chronic OIPN. We conducted a randomised controlled trial to investigate the efficacy of monosialotetrahexosylganglioside (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Likun, Liu, Rui, Huang, Dingzhi, Li, Hongli, Ning, Tao, Zhang, Le, Ge, Shaohua, Bai, Ming, Wang, Xia, Yang, Yuchong, Wang, XinYi, Chen, Xingyun, Gao, Zhiying, Luo, Laizhi, Yang, Yuanquan, Wu, Xi, Deng, Ting, Ba, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569480/
https://www.ncbi.nlm.nih.gov/pubmed/34765950
http://dx.doi.org/10.1016/j.eclinm.2021.101157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569480/
https://www.ncbi.nlm.nih.gov/pubmed/34765950
http://dx.doi.org/10.1016/j.eclinm.2021.101157

Ejemplares similares